Todd Tushla
Vice President of Investor Relations
Replay available
Neurocrine Biosciences, Inc. (NBIX) Q4 2025 Earnings Call
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Q4 2025 earnings conference call, held 2026-02-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Kyle Gano
Chief Executive Officer
Matt Abernathy
Chief Financial Officer
Eric Benevich
Chief Commercial Officer
Sanjay Kaswani
Chief Medical Officer
Samir Sedanti
Vice President of Strategy and Corporate Development
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Neurocrine Biosciences, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.060 -- 00:00:06.225 Hello and welcome everyone joining today's Neurocrin Biosciences fourth 00:00:06.225 -- 00:00:09.548 quarter and fiscal year 2025 earnings call. 00:00:09.548 -- 00:00:14.453 At this time all participants are in a listen-only mode. 00:00:14.453 -- 00:00:19.477 Later you will have the opportunity to ask questions during the question and 00:00:19.477 -- 00:00:24.642 answer session. To register to ask a question at any time please 00:00:24.642 -- 00:00:28.326 press star 1 on your telephone keypad. 00:00:28.326 -- 00:00:33.145 Please note this call is being recorded and We are standing by if you should need any 00:00:33.145 -- 00:00:38.733 assistance. And it is now my pleasure to turn the meeting over to Todd Tushla, 00:00:38.733 -- 00:00:42.138 Vice President of Investor Relations. Please go ahead. 00:00:42.138 -- 00:00:44.138 Happy 00:00:44.301 -- 00:00:48.527 Wednesday to everyone, and welcome to Nurocrine Biosciences' fourth quarter and 2025 00:00:48.527 -- 00:00:53.875 year-end earnings call. With me today are Kyle Gano, Chief Executive Officer, 00:00:53.875 -- 00:00:58.693 Matt Abernathy, Chief Financial Officer, Eric Benevich, Chief Commercial Officer, Sanjay 00:00:58.693 -- 00:01:03.478 Kaswani, Chief Medical Officer, and for the first time, we are very pleased to be joined 00:01:03.478 -- 00:01:08.143 by Samir Sedanti, Vice President of Strategy and Corporate Development. 00:01:08.143 -- 00:01:11.246 During today's call, we will be making forward-looking statements. 00:01:11.246 -- 00:01:14.850 These statements are subject to certain risks and uncertainties, and our actual results 00:01:14.850 -- 00:01:19.334 may differ materially. I encourage you to review the risk factors discussed in our latest 00:01:19.334 -- 00:01:23.939 S...